ponent, comparable to hemoglobin A, in human subjects. The present study was designed to observe the rate of Fe59 appearance in at least two hemoglobin components of a subject following the intravenous administration of Fe59.
MATERIALS AND METHODS
Except for L.B., who had thalassemia major, all the patients in this study had disseminated neoplastic disease in addition to their hemoglobin abnormalities. These patients were selected for study because 40 to 100 ,uc. of Fe5" could be given, and accurate measurement of Fe' activity in small amounts of hemoglobin components was thereby facilitated. Most of the patients received radiotherapy before or during the study period. Two patients (J. B. and L. B.) had received blood transfusions within Table I .
The isotopic iron was administered intravenously as either Fe' citrate or Fe' bound to human P, globulin.
Blood samples were obtained at intervals after the administration of the isotope and hemoglobin was prepared by the method of Drabkin except that AlCl3 was omitted from the saline washings of the erythrocytes. The final hemoglobin solutions were centrifuged at 15,000 x G for 30 minutes and converted to carbonmonoxyhemoglobin before electrophoretic or chromatographic separation of components. The hemoglobin of L.B. was separated by alkali denaturation of oxyhemoglobin. Electrophoretic separation of hemoglobin components was carried out in starch blocks by the method of Kunkel, Ceppellini, Muller-Eberhard and Wolf (1) . After a 16 hour run the dense mid-portion of each component was cut from the block, and the carbonmonoxyhemoglobin was eluted from the starch with water. The hemoglobin concentration and isotopic activity were determined on the eluates. The hemoglobin concentration was determined in a Coleman Universal Spectrophotometer and the radioactivity of a 2 ml. aliquot was measured in a welltype scintillation counter. Sufficient counts were recorded to secure an accuracy of at least 3 per cent.
For the separation of fetal hemoglobin, the alkali denaturation technique of Singer, Chernoff and Singer (2) was used in the case of L.B.; the only modification was the use of 0.5 ml. hemoglobin specimens. Alkali denaturation was not entirely satisfactory for the purpose of this study because of the dilution of hemoglobin F in the alkali resistant fraction. Consequently for the second patient with alkali resistant hemoglobin, a modification of the chromatographic technique of Morrison and Cook (3) was utilized for separating fetal hemoglobin. The fetal hemoglobin sample selected for assay was the most Major fractions of hemoglobin a). Sickle cell trait. Three patients with sickle cell trait were studied over periods ranging from 10 to 101 days. No significant difference in Fe59 incorporation between sickle cell hemoglobin and hemoglobin A, was observed in any of the three patients who were studied. Results in these patients are recorded in Table II. b). Hemoglobin C trait. The patient with hemoglobin C trait who was studied had been trans- fused six weeks prior to the administration of Fe59. The results of the study are recorded in Table III . Since the isotopic activity of hemoglobin A and C differed in the initial specimens obtained from this patient, the reliability of the observation was checked by separating larger amounts of hemoglobin A and C on successive electrophoretic analyses and subsequently preparing recrystallized hemin from each component. The radioactivity of the preparations of hemin recrystallized from the A and C hemoglobin components showed a C: A ratio of 1.25; the pooled hemoglobin components used for the crystallization had a radioactivity ratio for C and A hemoglobins of 1.4.1 In this patient the relatively higher radioactivity of the hemoglobin C fraction was attributed to dilution of the hemoglobin A fraction by the hemoglobin of previous transfusions. This hypothesis was sup- ported by the finding of approximately equal Fe59 activity in the hemoglobin A and C components isolated from the final blood specimen obtained 69 days after the administration of the, isotope and more than three months after the last transfusion. At that time hemoglobin A from previous transfusions had disappeared. c). Electrophoretically rapid abnormal hemoglobin. Patient S.P. who had an electrophoretically rapid abnormal hemoglobin was an American Negro; approximately 50 per cent of his hemoglobin had an electrophoretic mobility faster than hemoglobin A at pH 8.6. He was presumed to have hemoglobin J on the basis of electrophoretic mobility of hemoglobin specimens in acid and alkaline buffers (see Figure 1 ) (4), but no family studies could be carried out. Since this abnormal hemoglobin might also have been another electrophoretically rapid abnormal hemoglobin, e.g., hemoglobin N, rather than hemoglobin J, it is designated as "electrophoretically rapid hemoglobin component" or "J group hemoglobin" (5) in this study. The results of the studies of Fe59 incorporation in hemoglobin A and the rapid major component are recorded in Table IV . Again no significant difference in Fe59 incorporation was noted between hemoglobin A and the major abnormal fraction. d). Fetal hemoglobin. Patient J.R. had a large amount of fetal hemoglobin in association with multiple myeloma. By the method of alkali denaturation, the fetal hemoglobin amounted to 40 per cent of the total hemoglobin, and similar values were obtained by chromatographic techniques. The patient was known to have had a normal hemoglobin concentration during an unrelated brief illness .three years earlier; he did not have microcytosis and the values for hemoglobin A2 were normal. Consequently he probably belonged to the group of patients with normal hemoglobin concentration and "hereditary persistence of fetal hemoglobin production" recently summarized by Jacob and Raper (6) . In this patient the hemoglobin components were separated chromatographically for the Fe59 incorporation studies; the results (see Table V ,. a) showed the alkali resistant hemoglobin to have the same radioactivity as the remainder of the hemoglobin. Patient L.B. who had thalassemia major had required whole blood transfusions two to three times monthly for several years. He had been transfused three weeks before Fe59 incorporation studies were done. As a result of multiple transfusions, he had extensive hemosiderosis; decreased hemoglobin production and dilution of the isotope by increased storage iron probably accounted for the low levels of radioactivity observed in the hemoglobin. In this patient, the fetal hemoglobin was separated by alkali; the greater isotopic activity of the fetal component (see Table V , b) was attributed to dilution of hemoglobin A by previous transfusion.
Minor components of human hemoglobin
On starch electrophoresis, two minor components of hemoglobin, hemoglobin A2 and hemoglobin A8, described by Kunkel and Bearn (7), were isolated during studies of Patient O.G. (Table II) , and a few observations on hemoglobin A2 were made during the study of Patient S.P. (Table IV) . In Patient O.G. the isotopic activity of the electrophoretically rapidly moving hemoglobin A, component was significantly lower than the activity of the major fractions in the early period after the administration of Fe59. However, the relative isotopic activity of the A, component appeared to increase somewhat in the later specimens, although Fe59 activity never reached the values observed in the principal components. A less striking initial decrease in the isotopic activity of the minor basic component, hemoglobin A2, was also noted in O.G. and in S.P. Storage of the, hemoglobin specimens in the cold and repeating the separations after a period of 10 days did not significantly alter the relative isotopic activities of the components.
Rapid hemoglobin component in experimental animals
Preliminary experiments showed that shortly after the administration of Fe59, the "spear" or electrophoretically most rapid component of the hemoglobin of dogs, rabbits and mice exhibited Fe59 activity which was significantly lower than the isotopic activity of the main hemoglobin com-ponent. To test the effect of erythrocyte aging upon the relative activity of the slow component, two rabbits were given, respectively, 40 and 60 !Lc. of Fe59 and hemoglobin separations were carried out at intervals thereafter. The results of the experiments in these rabbits are recorded in Table  VI . If the life span of the rabbit erythrocyte is taken to be about 60 days (8, 9) , the increase in isotopic activity of the rapid hemoglobin component correlated well with cell aging.
DISCUSSION
Major and minor components of human hemoglobin Because hemoglobin S and hemoglobin A coexist in most of the erythrocytes of subjects with sickle cell trait, it is reasonable to suppose that both hemoglobins are synthesized simultaneously before maturation of the cell. If this is the case both hemoglobins would be expected to exhibit the same isotopic activity although the total amount of each might show considerable variability in different patients with the trait. In the present study Fe59 activity of the hemoglobins of the circulating erythrocytes was measured; this technique probably would not yield evidence distinguishing between simultaneous, alternating or sequential synthesis of different hemoglobins in the immature erythrocytes of the bone marrow. However, the study of Kunkel and Bearn (7) of minor human hemoglobin components and the data on Fe59 incorporation into minor hemoglobin components in this study indicate that the interrelationships of various hemoglobins are not necessarily simple since Fe59 activity of the hemoglobins may change with time. The fact that minor components exhibit lower isotopic activities than the normal major component has been interpreted as evidence of change in hemoglobin with erythrocyte aging (7), although other explanations are possible. Following the administration of Fe59 the minor rapid hemoglobin component, hemoglobin A8, showed low Fe59 activity which subsequently increased; in contrast, in the absence of previous transfusions, the two major components of hemoglobin in patients with sickle cell trait, hemoglobin C trait, alkali resistant hemoglobin, and "group J hemoglobin" trait both showed comparable Fe59 activity throughout the period of study. These observations provide some evidence against changes in major hemoglobin components with erythrocyte aging.
Studies in patients who had been previously transfused (L.B. and J.B.) demonstrated the effect of previous transfusions in diluting hemoglobin A, with resultant higher isotopic activity in the fetal and hemoglobin C components.
From the data obtained by recrystallization of heme from the hemoglobin components isolated by starch electrophoresis, most of the radioactivity appeared to be due to Fe59 in the heme of hemoglobin, although some (nonspecific) adsorption of the isotope elsewhere or incorporation into heme enzymes may have occurred.
In view of the decreased Fe59 activity of the fast component (A8) of normal adult hemoglobin, the data concerning Fe59 incorporation in the patient with an electrophoretically rapid major component are of particular interest. In that patient, S.P., Fe59 incorporation into the electrophoretically rapid hemoglobin did not differ significantly from the incorporation into hemoglobin A1. However, lower radioactivity of small amounts of hemoglobin A8 might not be detected in the presence of the large amount of rapid hemoglobin. The findings of the present study concerning major components of hemoglobin are in agreement with those of Motulsky who found no significant differences in Fe59 incorporation in major hemoglobin components in patients with hemoglobin H-thalassemia and sickle cell-hemoglobin C disease (10 
Electrophoretically rapid hemoglobin component in experimental animals
Studies of Fe59 incorporation into the electrophoretically rapid component of hemoglobin in two normal rabbits yielded data which could be better correlated with erythrocyte aging than the data obtained in man. In these rabbits a gradual increase in the isotopic activity of the fast component was noted during the first 48 days of the study. The decline which was observed at 70 days in the relative Fe59 activity of the most rapid hemoglobin component in one of these animals may have been related to reincorporation of the isotopic iron into the newly formed main hemoglobin component.
These observations in experimental animals indicate that an electrophoretically rapid hemoglobin may be formed in aging erythrocytes as suggested by Kunkel and Bearn (7). However, our preliminary studies of young and old erythrocytes separated by osmotic hemolysis (11, 12 ) have failed to demonstrate differences in relative isotopic activity between the hemoglobin components in the young resistant cells as contrasted with the older more fragile cells. Furthermore, the hypothesis that erythrocyte aging is responsible for the formation of this electrophoretically rapid component fails to explain the appearance of significant isotopic activity in the rapid component within a few days after the administration of Fe59 when Fe59 labeled hemoglobin should be present only in young red blood cells.
Further studies of this electrophoretically rapid hemoglobin component may disclose a correlation with decreasing enzyme levels in aging erythrocytes. However, the influence of factors other than cell aging (for example, hemoglobin distribution within the erythrocyte) on the formation of this electrophoretically rapid hemoglobin component should also be studied.
SUM MARY
1. The incorporation of Fe59 into the major components of hemoglobin in individuals with sickle cell trait, hemoglobin C trait, electrophoretically rapid major hemoglobin component of the "J group," probable hereditary persistence of fetal hemoglobin production and thalassemia major revealed no difference in Fe59 incorporation in the major components.
2. Observations on the minor electrophoretically rapid components of hemoglobin in a patient with sickle cell trait confirmed the observations of Kunkel and Bearn (7) that the isotopic activity of this hemoglobin A. component gradually increased during the 50 day period of study.
3. The studies of the incorporation of Fe59 into the electrophoretically rapid component of the hemoglobin of rabbits also supported the hypothesis that the formation of an electrophoretically rapid hemoglobin component in experimental animals is correlated with erythrocyte aging. The possibility that factors other than cell aging may influence the formation of this electrophoretically rapid normal component was discussed.
